Conditions: Transplant, Liver
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 30
Healthy volunteers: no

Brief summary:
To study spironolactone to prevent calcineurin inhibitor (CNI) kidney injury.

Detailed description:
The aim of this study is to determine if spironolactone decreases nephrotoxicity from calcineurin inhibitors in liver transplant recipients and to determine the best study of renal function in liver transplant recipients.

Arms:
arm 1: standard of care, nontreatment arm 2: spironolactone

Interventions: intervention 1: Spironolactone
Intervention descriptions: intervention 1: spironolactone 25 mg up to 50 mg

Protocol document:
Prot_SAP_000.pdf: